彭布罗利珠单抗
医学
随机对照试验
间皮瘤
内科学
肿瘤科
病理
免疫疗法
癌症
作者
Aaron S. Mansfield,Jun Vivien Yin,Penelope A. Bradbury,David J. Kwiatkowski,Shiven B. Patel,Lyudmila Bazhenova,Patrick M. Forde,Yanyan Lou,Paul Dizona,Liza C. Villaruz,Susanne M. Arnold,Maya Khalil,Hedy L. Kindler,Marianna Koczywas,J. A. de Freitas Pacheco,Christian Rolfo,Bing Xia,Elizabeth Mikula,Li Chen,Kashish Patel
出处
期刊:Lung Cancer
[Elsevier BV]
日期:2024-08-13
卷期号:195: 107928-107928
被引量:2
标识
DOI:10.1016/j.lungcan.2024.107928
摘要
The mesothelin-targeting antibody-drug conjugate anetumab ravtansine was evaluated in combination with the programmed cell death-1 (PD-1) inhibitor pembrolizumab based on the common expression of mesothelin and reports of activity in mesothelioma.
科研通智能强力驱动
Strongly Powered by AbleSci AI